SM

Subash Munshi

Active Director Director DIN 08839096
DIN 08839096 First appointment Aug 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Subash Munshi

Data last updated:

Subash Munshi is a Director at Ess Emm Pharma Private Limited (since 2020). The company operates in Pharma. Ess Emm Pharma Private Limited reported revenue of ₹2.28 Cr (FY 2025).

DIN 08839096
Primary Designation Director
Industry Pharma
First Appointment 19 Aug 2020
Oldest Company Age 6 yrs
Largest company Ess Emm Pharma Private Limited · ₹2.28 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ess Emm Pharma Private Limited U51909HR2020PTC088455
Director19 Aug 20202020₹2.28 Cr (FY 2025)Active

Board colleagues of Subash Munshi

NameDINCompanyDesignation
Siddharth Munshi08839097Ess Emm Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ess Emm Pharma Private Limited
Premium access

Shareholding and investment profile for Subash Munshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subash Munshi

Subash Munshi currently holds 1 directorship: Ess Emm Pharma Private Limited (Director, since 19 Aug 2020, revenue ₹2.28 Cr (FY 2025)).

Subash Munshi was first appointed on 19 Aug 2020 as Director at Ess Emm Pharma Private Limited.

The current boards of Subash Munshi's companies include Siddharth Munshi (Ess Emm Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available